| Search by tag or site | Login to my blog ? Start my own blog |
 |
BioHealth InvestorBioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network. |
Mylan's Shareholders Act As Lbo Lenders
Posted on 05/14/2007 22:46:58 | Link | Post Comment
by Jon C. Ogg
24/7 Wall St.
Mylan Labs (MYL) is seeing its shares take a beating because it is acquiring Merck KGaA's generic unit and Mylan is the acquirer in what is a very leveraged buyout. It isn't just the fact that there will be dilution, it's the fact that the leverage today and tomorrow is going to be a large burden for years ahead. This also just took away almost any shot that Mylan Labs could ever be considered a potential takeover target itself.
The company is taking 2 steps back to jump 6 steps forward and the 6 steps forward won't come for several years.
Continue article at 247WallSt.com
RELATED READING:
- Pfizer and Mylan Fight to Defend Norvasc Exclusivity
- FDA Refuses to Approve Any ANDAs for Generic Norvasc Besides Mylan's
_____________________
24/7 Wall St.
Mylan Labs (MYL) is seeing its shares take a beating because it is acquiring Merck KGaA's generic unit and Mylan is the acquirer in what is a very leveraged buyout. It isn't just the fact that there will be dilution, it's the fact that the leverage today and tomorrow is going to be a large burden for years ahead. This also just took away almost any shot that Mylan Labs could ever be considered a potential takeover target itself.The company is taking 2 steps back to jump 6 steps forward and the 6 steps forward won't come for several years.
Continue article at 247WallSt.com
RELATED READING:
- Pfizer and Mylan Fight to Defend Norvasc Exclusivity
- FDA Refuses to Approve Any ANDAs for Generic Norvasc Besides Mylan's
_____________________
- Mri To Lead Growth In Medical-imaging Market
- Malaria And Hiv - Eradication And Treatment
- Dragon’s New Production Process To Cut Costs
- Mrsa Update: Cepheid, Basilea And Nektar
- If Only Us Health Care Could Be More Like The Patriots (or Even The Red Sox) And Less Like The Yankees
- Ludwig von Mises Institute
- Credit Bloggers
- Millionaire Now! by Larry Nusbaum
- Don't Mess With Taxes
- Poor and Stupid
Examples
Morpheus Trading - Sun Aug 24, 2008 06:22AM
NOTE: Please click on the charts below to enlarge them if [read more]
NOTE: Please click on the charts below to enlarge them if [read more]
Morpheus Trading - Thu Aug 28, 2008 02:39AM
NOTE: Please click on the charts below to enlarge them if [read more]
NOTE: Please click on the charts below to enlarge them if [read more]
Boucher On The Big Picture - Thu Aug 28, 2008 05:01PM
Market Needs to Show Volume and Breadth To Signal Next M [read more]
Market Needs to Show Volume and Breadth To Signal Next M [read more]
<< My Home | TheMoneyBlogs Home